1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. FULCRUM THERAPEUTICS INC
Fulcrum Therapeutics Inc XNAS: FULC

Fulcrum Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

about

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule ...

Read More
6.65 0.02 (0.30%)
28.49% Fall from 52W High
196.9K
XNAS Volume

XNAS 28 Aug, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
Not Eligible
-
Valuation Score
Expensive Valuation
10.0 / 100
Momentum Score
Technically Moderately Bullish
64.2 / 100
Analyst Price Target
11
1Yr Price target upside is 66%
7 analysts

15

S

5

W

1

O

2

T

SWOT Analysis

Fulcrum Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..